Related Experiment Videos
Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking
Linda J Pike1, Laurieann Casey
1Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, 660 South Euclid Avenue, Box 8231, St. Louis, Missouri 63110, USA. pike@biochem.wustl.edu
Biochemistry
|August 7, 2002
Summary
Cholesterol depletion enhances epidermal growth factor receptor (EGFR) activity by releasing it from lipid rafts, boosting downstream signaling. This finding reveals a new mechanism for regulating EGFR function.
Area of Science:
- Cellular Biology
- Biochemistry
- Molecular Signaling
Background:
- Cellular cholesterol levels influence various signal transduction pathways.
- The specific mechanisms and locations of cholesterol's modulation of these pathways remain unclear.
Purpose of the Study:
- To investigate how cholesterol content affects the epidermal growth factor (EGF) signaling pathway.
- To identify the specific locus within the pathway modulated by cholesterol.
Main Methods:
- Cholesterol depletion using methyl-beta-cyclodextrin.
- Measurement of cell surface (125)I-EGF binding.
- In vivo and in vitro EGF receptor autophosphorylation assays.
- Analysis of EGF receptor localization in lipid rafts.
Main Results:
- Cholesterol depletion increased cell surface EGF binding by 40%.
- EGF receptor autophosphorylation increased 2-5 fold without changes in dephosphorylation rate.
- Methyl-beta-cyclodextrin treatment enhanced intrinsic EGF receptor tyrosine kinase activity.
- EGF receptors were released from cholesterol-enriched lipid rafts upon cholesterol depletion.
- Cholesterol depletion inhibited EGF internalization and receptor down-regulation.
Conclusions:
- Cholesterol localization within lipid rafts partially suppresses EGF receptor binding and kinase activity.
- Cholesterol depletion releases EGF receptors from lipid rafts, relieving this functional inhibition.
- This mechanism contributes to enhanced EGF-stimulated downstream signaling, including MAP kinase activation.